CVS Health Corp (CVS)
78.44
+0.54 (0.69%)
NYSE · Last Trade: Oct 13th, 10:56 PM EDT
Detailed Quote
Previous Close | 77.90 |
---|---|
Open | 77.54 |
Bid | 77.76 |
Ask | 78.21 |
Day's Range | 77.37 - 79.67 |
52 Week Range | 43.56 - 79.68 |
Volume | 8,436,014 |
Market Cap | 103.51B |
PE Ratio (TTM) | 21.85 |
EPS (TTM) | 3.6 |
Dividend & Yield | 2.660 (3.39%) |
1 Month Average Volume | 6,878,891 |
Chart
About CVS Health Corp (CVS)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
News & Press Releases
CVS stock shows strong technical momentum and a high-quality breakout setup, offering a potential entry point for traders.
Via Chartmill · October 11, 2025
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Via StockStory · October 10, 2025
The stock market stumbled Friday after President Donald Trump threatened a sweeping increase in tariffs on Chinese imports, sending equity indices and risk sentiment sharply lower. • AMD shares are retreating from recent levels. See what is driving the move here.
Via Benzinga · October 10, 2025
CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes Wall Street After Medicare Star Ratings Updatestocktwits.com
Via Stocktwits · October 9, 2025
UnitedHealth Stock Slips Premarket Amid Medicare Advantage Pullback; Humana, CVS Also Tighten Coveragestocktwits.com
Via Stocktwits · October 2, 2025
Confluent explores a sale, Rothschild exits The Economist, Helsing buys Blue Ocean, Zimmer expands robotics, and Omnicare files bankruptcy.
Via Benzinga · October 10, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Via Chartmill · October 10, 2025
Via Benzinga · October 9, 2025
Amazon (NASDAQ: AMZN) continues to aggressively expand its strategic business developments, solidifying its e-commerce dominance through frequent Prime discount events and making significant inroads into the pharmacy sector. These initiatives, spanning from late 2023 through 2025, are designed to strengthen customer loyalty, capture new markets, and leverage Amazon's robust logistics
Via MarketMinute · October 8, 2025
Louisville, KY – October 3, 2025 – Humana Inc. (NYSE: HUM) witnessed a significant surge in its stock price today, jumping an impressive 11.9% in early trading. This substantial gain has positioned the managed care giant as a top performer in the financial markets, reflecting robust investor confidence and potentially signaling
Via MarketMinute · October 3, 2025
The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this particular standoff especially perilous is the accompanying delay in the release of critical economic data. As agencies responsible for tracking the nation's financial
Via MarketMinute · October 2, 2025
New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government shutdown and a disappointing jobs report. As investors sought refuge in defensive plays and reacted to
Via MarketMinute · October 1, 2025
Pfizer's deal with TrumpRx for steep drug discounts could impact UnitedHealth, Eli Lilly, and CVS. Here's how...
Via Benzinga · October 1, 2025
Washington D.C., September 30, 2025 – As the deadline for federal funding approaches, the specter of a potential US government shutdown is sending ripples of anxiety through global financial markets, with stock futures experiencing heightened volatility and a palpable sense of uncertainty. The looming political impasse, a recurrent feature of
Via MarketMinute · September 30, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cardinal Health (NYSE:CAH) and its peers.
Via StockStory · September 28, 2025
The healthcare sector experienced a significant downturn on Thursday, September 25, 2025, shedding a notable -1.67% of its value and sending ripples of concern through the broader financial markets. This sharp decline, which outpaced the overall market's performance, immediately signaled investor apprehension regarding a sector traditionally viewed as defensive
Via MarketMinute · September 26, 2025
The Centers for Medicare & Medicaid Services (CMS) is poised to usher in a new era of healthcare administration with the upcoming launch of the Wasteful and Inappropriate Service Reduction (WISeR) Model. This groundbreaking pilot program, set to begin on January 1, 2026, will integrate artificial intelligence (AI) into the prior
Via MarketMinute · September 25, 2025
CVS has broken past 52-week highs, and chances are this newfound optimism is going to carry the stock even higher in the coming quarters.
Via MarketBeat · September 25, 2025
The healthcare sector stands on the precipice of a monumental transformation, driven by the relentless advance of Artificial Intelligence (AI). From streamlining administrative tasks to enhancing diagnostic accuracy, AI promises a future of more efficient, accessible, and personalized care. However, this technological revolution is not without its complexities, sparking debates
Via MarketMinute · September 24, 2025
The healthcare payer industry is reeling following a challenging second quarter, epitomized by UnitedHealth Group's (NYSE: UNH) significant earnings miss and the deepening shadow of a federal Medicare fraud investigation. These developments are not isolated incidents but rather stark indicators of mounting pressures within the health insurance sector, characterized by
Via MarketMinute · September 22, 2025
The healthcare sector is currently experiencing a period of profound transformation, marked by a fascinating dichotomy: groundbreaking medical innovations are driving unprecedented growth for some, while intense regulatory scrutiny and escalating costs pose significant challenges for others. This intricate interplay between scientific advancement and a complex operating environment is reshaping
Via MarketMinute · September 22, 2025
Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a fast-growing consumer health and wellness company, today announced two major leadership appointments to accelerate growth in the $100 billion+ global functional beverage and energy drink market .
Via AB Newswire · September 22, 2025
Aetna, a CVS Health unit, is expanding its Clinical Collaboration program to 10 hospitals to cut readmissions.
Via Benzinga · September 22, 2025
UnitedHealth Group (NYSE: UNH), a titan in the U.S. healthcare industry, is grappling with a formidable array of financial and operational challenges that are poised to exert immediate and substantial downward pressure on its Q3 2025 Earnings Per Share (EPS) estimates. A confluence of escalating high-acuity care costs, unfavorable
Via MarketMinute · September 19, 2025